Trupanion (NASDAQ:TRUP) Director Murray Low Sells 6,537 Shares of Company Stock

Trupanion, Inc. (NASDAQ:TRUP) Director Murray Low sold 6,537 shares of Trupanion stock in a transaction dated Tuesday, November 10th. The shares were sold at an average price of $34.21, for a total transaction of $223,630.77. Following the completion of the sale, the director owned 147,997 shares in the company, valued at approximately $5,062,977.37. This represents a 4.23% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Trupanion Trading Down 0.2%

Trupanion stock opened at $34.30 on Friday. Trupanion, Inc. has a 52-week low of $21.16 and a 52-week high of $39.61. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.24. The firm has a market capitalization of $1.48 billion, a price-to-earnings ratio of 56.23, a PEG ratio of 1.59 and a beta of 1.27. The firm has a 50-day moving average price of $27.61 and a two-hundred day moving average price of $26.73.

Trupanion (NASDAQ:TRUP) last announced its quarterly earnings results on Thursday, November 5th. The financial services provider reported $0.21 EPS for the quarter, beating the consensus estimate of $0.17 by $0.04. The company had revenue of $405.59 million for the quarter, compared to analyst estimates of $402.53 million. Trupanion had a net margin of 1.71% and a return on equity of 6.71%. During the same quarter last year, the business earned $0.13 earnings per share. Sell-side analysts expect that Trupanion, Inc. will post 0.68 earnings per share for the current year.

Institutional Trading of Trupanion

A number of institutional investors have recently bought and sold shares of TRUP. Sterling Capital Management LLC raised its stake in shares of Trupanion by 843.7% during the 3rd quarter. Sterling Capital Management LLC now owns 1,123 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 1,004 shares in the last quarter. Kelleher Financial Advisors acquired a new stake in shares of Trupanion during the 2nd quarter valued at about $42,000. Parallel Advisors LLC grew its stake in shares of Trupanion by 1,831.9% in the 1st quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider’s stock valued at $47,000 after buying an additional 1,722 shares in the last quarter. Quantbot Technologies LP bought a new stake in shares of Trupanion in the 2nd quarter valued at approximately $89,000. Finally, Fifth Third Bancorp grew its stake in shares of Trupanion by 2,911.1% in the 1st quarter. Fifth Third Bancorp now owns 7,588 shares of the financial services provider’s stock valued at $194,000 after buying an additional 7,336 shares in the last quarter.

Analyst Ratings Changes

A number of analysts have recently weighed in on TRUP shares. Zacks Research lowered shares of Trupanion from a “strong-buy” rating to a “hold” rating in a research note on Monday, August 24th. Piper Sandler downgraded Trupanion from an “overweight” rating to a “neutral” rating and dropped their price objective for the stock from $45.00 to $32.00 in a research note on Wednesday, August 26th. Stifel Nicolaus increased their price objective on Trupanion from $29.00 to $34.00 and gave the company a “hold” rating in a research report on Monday. Cantor Fitzgerald lifted their target price on shares of Trupanion from $30.00 to $33.00 and gave the stock a “neutral” rating in a research report on Monday. Finally, Weiss Ratings raised Trupanion from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, September 29th. One equities research analyst has rated the stock with a Buy rating and five have given a Hold rating to the stock. According to MarketBeat, Trupanion presently has a consensus rating of “Hold” and an average price target of $40.00.

Trupanion News Summary

These are some of the TRUP news items that stood out recently:

• Positive Sentiment: Two analyst headlines say Cantor Fitzgerald and Stifel Nicolaus expect Trupanion’s stock to rise, offering support for the bullish outlook. The articles provided do not include target prices or further rationale. Cantor Fitzgerald analyst article Stifel Nicolaus analyst article
• Positive Sentiment: Trupanion was recognized among Canada’s best companies for customer service by Newsweek, a reputational positive that may support its brand. Newsweek customer-service recognition
• Negative Sentiment: Three insiders disclosed sales: Director Howard Rubin sold 30,000 shares, Director Murray Low sold 6,537, and CEO Margaret Tooth sold 2,000. These transactions could weigh on sentiment, though each retained a substantial holding; Tooth’s sale was made under a pre-arranged Rule 10b5-1 plan. Rubin SEC filing Low SEC filing Tooth SEC filing

Trupanion Company Profile

Trupanion provides medical insurance for cats and dogs, offering coverage for eligible veterinary care. Its products are designed to help pet owners manage unexpected costs from illnesses and injuries, subject to policy terms and exclusions. The company also provides software and payment services that enable participating veterinary practices to submit claims and receive payments directly, reducing the need for customers to pay covered costs upfront and seek reimbursement. Founded in 2000 and headquartered in Seattle, Trupanion serves customers in the United States and Canada.